Ganau, M.; Paris, M.; Syrmos, N.; Ganau, L.; Ligarotti, G.K.I.; Moghaddamjou, A.; Prisco, L.; Ambu, R.; Chibbaro, S.
How Nanotechnology and Biomedical Engineering Are Supporting the Identification of Predictive Biomarkers in Neuro-Oncology. Medicines 2018, 5, 23.
https://doi.org/10.3390/medicines5010023
AMA Style
Ganau M, Paris M, Syrmos N, Ganau L, Ligarotti GKI, Moghaddamjou A, Prisco L, Ambu R, Chibbaro S.
How Nanotechnology and Biomedical Engineering Are Supporting the Identification of Predictive Biomarkers in Neuro-Oncology. Medicines. 2018; 5(1):23.
https://doi.org/10.3390/medicines5010023
Chicago/Turabian Style
Ganau, Mario, Marco Paris, Nikolaos Syrmos, Laura Ganau, Gianfranco K.I. Ligarotti, Ali Moghaddamjou, Lara Prisco, Rossano Ambu, and Salvatore Chibbaro.
2018. "How Nanotechnology and Biomedical Engineering Are Supporting the Identification of Predictive Biomarkers in Neuro-Oncology" Medicines 5, no. 1: 23.
https://doi.org/10.3390/medicines5010023
APA Style
Ganau, M., Paris, M., Syrmos, N., Ganau, L., Ligarotti, G. K. I., Moghaddamjou, A., Prisco, L., Ambu, R., & Chibbaro, S.
(2018). How Nanotechnology and Biomedical Engineering Are Supporting the Identification of Predictive Biomarkers in Neuro-Oncology. Medicines, 5(1), 23.
https://doi.org/10.3390/medicines5010023